Durability of First-Line Antiretroviral Regimens in the era of Integrase Inhibitors: A Cohort of HIV-Positive Individuals in Spain, 2014–2015
Inmaculada Jarrín(Instituto de Salud Carlos III), Santiago Moreno(Universidad El Bosque), Rosario Palacios(Bellvitge University Hospital), Cristina Moreno(Universidad de Alcalá), Joaquim Peraire(Instituto de Salud Carlos III), Miguel Górgolas(Hospital Universitario Fundación Jiménez Díaz), Inés Suárez‐García(Centro de Investigación Biomédica en Red), Jorge Del Romero, María Tasias(Hospital Universitari i Politècnic La Fe)
Cited by 9
Related Papers
Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies
|The Lancet HIV|2023|506
Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV–HCV International Panel
|AIDS|2002|443
Description of COVID-19 in HIV-infected individuals: a single-centre, prospective cohort
|The Lancet HIV|2020|396
Risk Factors and Outcomes for Late Presentation for HIV-Positive Persons in Europe: Results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE)
|PLoS Medicine|2013|362
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
|Annals of Internal Medicine|2020|342